Unknown

Dataset Information

0

Glutamatergic modulation of auditory information processing in the human brain.


ABSTRACT: BACKGROUND:Auditory mismatch negativity (MMN) and P300 event-related potentials (ERPs) are reduced in schizophrenia patients and healthy volunteers administered the N-methyl-D-aspartate glutamate receptor antagonist, ketamine. In rodents, N-acetylcysteine (NAC), a stimulator of the cystine-glutamate exchanger, attenuates the cognitive and behavioral effects of N-methyl-D-aspartate receptor antagonists. On the basis of these findings, we tested whether NAC would reduce ketamine effects on behavior, MMN, and P300 in healthy humans. METHODS:This randomized, double-blind, placebo-controlled study consisted of 2 test days during which subjects (n = 16) were administered oral NAC (3000 mg in divided doses) or matching placebo 165 min before the infusion of saline and then ketamine (as a bolus of .23 mg/kg over 1 min followed by .58 mg/kg for 30 min, and then .29 mg/kg for 40 min) in a fixed order. Behavioral and ERP data including auditory MMN and P300 were collected during each test day. RESULTS:Ketamine produced psychotic-like positive symptoms, reductions in working memory and sustained attention performance, and amplitude reductions for the frequency- and intensity-deviant MMNs and P300. NAC pretreatment did not reduce the behavioral or ERP effects of ketamine. In addition, NAC reduced frequency-deviant MMN amplitude and increased target and novelty P3 amplitudes. The decrements in frequency-deviant MMN amplitude produced by ketamine and NAC were not additive. CONCLUSIONS:NAC did not attenuate the effects of ketamine in humans, in contrast to previous studies in animals. NAC merits further investigation as a cognitive enhancing agent due to its ability to increase the P300 amplitude.

SUBMITTER: Gunduz-Bruce H 

PROVIDER: S-EPMC3290754 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Glutamatergic modulation of auditory information processing in the human brain.

Gunduz-Bruce Handan H   Reinhart Robert M G RM   Roach Brian J BJ   Gueorguieva Ralitza R   Oliver Stephen S   D'Souza Deepak C DC   Ford Judith M JM   Krystal John H JH   Mathalon Daniel H DH  

Biological psychiatry 20111029 11


<h4>Background</h4>Auditory mismatch negativity (MMN) and P300 event-related potentials (ERPs) are reduced in schizophrenia patients and healthy volunteers administered the N-methyl-D-aspartate glutamate receptor antagonist, ketamine. In rodents, N-acetylcysteine (NAC), a stimulator of the cystine-glutamate exchanger, attenuates the cognitive and behavioral effects of N-methyl-D-aspartate receptor antagonists. On the basis of these findings, we tested whether NAC would reduce ketamine effects on  ...[more]

Similar Datasets

| S-EPMC7490710 | biostudies-literature
| S-EPMC8084811 | biostudies-literature
| S-EPMC4641005 | biostudies-literature
| S-EPMC2638814 | biostudies-other
| S-EPMC2652872 | biostudies-literature
| S-EPMC6869517 | biostudies-literature
| S-EPMC10041146 | biostudies-literature
| S-EPMC4164774 | biostudies-literature
| S-EPMC8828878 | biostudies-literature
| S-EPMC5453308 | biostudies-literature